S-phase modulation by irinotecan: pilot studies in advanced solid tumors N. RamnathN. KhushalaniY. M. Rustum Original Article 10 June 2005 Pages: 447 - 454
Correlation of pharmacokinetics with the antitumor activity of Cetuximab in nude mice bearing the GEO human colon carcinoma xenograft F. R. LuoZ. YangF. Y. Lee Original Article 10 June 2005 Pages: 455 - 464
Polymorphic tandem repeat sequences of the thymidylate synthase gene correlates with cellular-based sensitivity to fluoropyrimidine antitumor agents Ayako YawataSu-Ryang KimJun-ichi Sawada Original Article 26 May 2005 Pages: 465 - 472
Augmenting tumor sensitivity to topotecan by transient hypoxia Eva L. LundLasse T. HansenPaul E. G. Kristjansen Original Article 13 May 2005 Pages: 473 - 480
Biweekly oxaliplatin combined with oral capecitabine (OXXEL regimen) as first-line treatment of metastatic colorectal cancer patients: a Southern Italy Cooperative Oncology Group phase II study P. ComellaB. MassiddaR. Casaretti Original Article 18 May 2005 Pages: 481 - 486
Irinotecan combined with docetaxel in pre-treated metastatic breast cancer patients: a phase II study G. P. StathopoulosD. TsavdaridisJ. Xynotroulas Original Article 03 May 2005 Pages: 487 - 491
Pharmacokinetics of liquid calcitriol formulation in advanced solid tumor patients: comparison with caplet formulation Josephia R. MuindiDouglas M. PotterDonald L. Trump Original Article 26 May 2005 Pages: 492 - 496
Investigation of the influence of modulation of P-glycoprotein by a multiple dosing regimen of tamoxifen on the pharmacokinetics and toxicodynamics of doxorubicin Ramin DarvariMehdi Boroujerdi Original Article 04 June 2005 Pages: 497 - 509
Combination chemotherapy with gemcitabine and biotherapy with opioid growth factor (OGF) enhances the growth inhibition of pancreatic adenocarcinoma Ian S. ZagonJeffrey R. JaglowskiPatricia J. McLaughlin Original Article 10 June 2005 Pages: 510 - 520
Phase I study of etoposide, cisplatin and irinotecan triplet in patients with advanced-stage small-cell lung cancer E. BriasoulisE. SamantasN. Pavlidis Original Article 15 June 2005 Pages: 521 - 528
Spectrophotometric investigation of the chemical compatibility of the anticancer drugs irinotecan-HCl and epirubicin-HCl in the same infusion solution Filiz Arioz OzdemirBeril AnilanmertMursit Pekin Original Article 10 June 2005 Pages: 529 - 534
Magnesium depletion enhances cisplatin-induced nephrotoxicity. H. LajerM. KristensenT. E. N. Jonassen Original Article 10 June 2005 Pages: 535 - 542
Hyperacetylation enhances the growth-inhibitory effect of all-trans retinoic acid by the restoration of retinoic acid receptor β expression in head and neck squamous carcinoma (HNSCC) cells Young Mi WhangEun Jung ChoiYeul Hong Kim Original Article 16 June 2005 Pages: 543 - 555